MicroRNA-21 in Cardiovascular Disease
نویسندگان
چکیده
منابع مشابه
MicroRNA and Cardiovascular Disease
1Departments of Cardiothoracic Surgery, Central South University, Changsha 410011, China 2Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305, USA 3Warsaw University of Life Sciences, 02-787 Warsaw, Poland 4Chang Gung Memorial Hospital, Keelung 20445, Taiwan 5Institutes of Metabolism and Endocrinology, Central South University, Changsha 41001...
متن کاملMicroRNA and Cardiovascular Disease 2016
1Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha 410011, China 2Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305, USA 3Departments of Cardiothoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China 4Warsaw University of Life Sciences, 02-787 W...
متن کاملMicroRNA therapeutics for cardiovascular disease
MicroRNAs (miRNAs) are short, single-stranded, noncoding RNAs that exert their function through annealing with complementary sequences in specific messenger RNAs (mRNAs) to inhibit their translation into proteins. Even though it was only a decade ago that the first human miRNA was discovered, therapeutics to regulate miRNA function are already entering the clinical space. The main reasons for t...
متن کاملMicroRNA regulation of autophagy in cardiovascular disease.
Autophagy, a form of lysosomal degradation capable of eliminating dysfunctional proteins and organelles, is a cellular process associated with homeostasis. Autophagy functions in cell survival by breaking down proteins and organelles and recycling them to meet metabolic demands. However, aberrant up regulation of autophagy can function as an alternative to apoptosis. The duality of autophagy, a...
متن کاملCell Therapy in Cardiovascular Disease
Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiovascular Translational Research
سال: 2010
ISSN: 1937-5387,1937-5395
DOI: 10.1007/s12265-010-9169-7